Plan - FYE March 2018

	TOP

	Financial Results - For the FYE March 2017 -

	Contents

	1. Overview for the FYE March 2017

	2. Outlook for the FYE March 2018 Food: Increase Income - Grow Sales of Core Products and Reduce Cost Food: Expand Domestic Share of Core Products - Accelerate Selection and Concentration Food: Continue Structural Reforms Food: Overseas Business - Stabilize Profitability and Challenge for Further Growth Pharma: Increase Income - Focus Resources on Core Domains, Steady Sales Growth and Further Low-Cost Operations Pharma: Steady sales growth in Japan and overseas Pharma: Further Expand Generic Drug Business - Add New Business Model Plan - FYE March 2018 Use of Cash Flows Summary - Progress in STEP UP 17 Strategy

	3. The Meiji Group 2026 Vision (outline)

	Appendix

	Back cover

Consolidated results

Consolidated operating income: JPY 94.5 billion, operating margin 7.5%

Net income: JPY 6.1 billion, largely unchanged YoY

-Incorporate extraordinary losses approx. JPY 4.0 billion, losses on retirement of fixed assets - incurred due to structural reforms

-Not incorporate extraordinary income into FYE March 2018 plan